Palladium(II) Pincer Complexes of Functionalized Amides with S-Modified Cysteine and Homocysteine Residues: Cytotoxic Activity and Different Aspects of Their Biological Effect on Living Cells.
Svetlana G ChurusovaDiana V AleksanyanEkaterina Yu RybalkinaOlga Yu SusovaAlexander S PeregudovValentina V BrunovaEvgenii I GutsulZinaida S KlemenkovaYulia V NelyubinaValentina N GlushkoVladimir A KozlovPublished in: Inorganic chemistry (2021)
In the search for potential new metal-based antitumor agents, two series of nonclassical palladium(II) pincer complexes based on functionalized amides with S-modified cysteine and homocysteine residues have been prepared and fully characterized by 1D and 2D NMR (1H, 13C, COSY, HMQC or HSQC, 1H-13C, and 1H-15N HMBC) and IR spectroscopy and, in some cases, X-ray diffraction. Most of the resulting complexes exhibit a high level of cytotoxic activity against several human cancer cell lines, including colon (HCT116), breast (MCF7), and prostate (PC3) cancers. Some of the compounds under consideration are also efficient in both native and doxorubicin-resistant transformed breast cells HBL100, suggesting the prospects for the creation of therapeutic agents based on the related compounds that would be able to overcome drug resistance. An analysis of different aspects of their biological effects on living cells has revealed a remarkable ability of the S-modified derivatives to induce cell apoptosis and efficient cellular uptake of their fluorescein-conjugated counterpart, confirming the high anticancer potential of Pd(II) pincer complexes derived from functionalized amides with S-donor amino acid pendant arms.
Keyphrases
- living cells
- fluorescent probe
- single molecule
- high resolution
- quantum dots
- cell cycle arrest
- induced apoptosis
- prostate cancer
- amino acid
- endothelial cells
- magnetic resonance
- cell proliferation
- solid state
- molecularly imprinted
- photodynamic therapy
- drug delivery
- magnetic resonance imaging
- reduced graphene oxide
- computed tomography
- papillary thyroid
- single cell
- cell death
- risk assessment
- squamous cell carcinoma
- squamous cell
- cancer therapy
- contrast enhanced
- signaling pathway
- current status